RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Enzymatica AB (publ) Stock

Enzymatica AB (publ) P/S 2024

Enzymatica AB (publ) P/S

8.85

Ticker

ENZY.ST

ISIN

SE0003943620

WKN

A1WZEV

As of Aug 18, 2024, Enzymatica AB (publ)'s P/S ratio stood at 8.85, a 1.37% change from the 8.73 P/S ratio recorded in the previous year.

The Enzymatica AB (publ) P/S history

Enzymatica AB (publ) Aktienanalyse

What does Enzymatica AB (publ) do?

Enzymatica AB (publ) is a Swedish healthcare company that specializes in the development, production, and marketing of enzyme technology. It was founded in 2007 and is headquartered in Lund, Sweden. The company is listed on the Nasdaq Stockholm. Enzymatica AB (publ) ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Enzymatica AB (publ)'s P/S Ratio

Enzymatica AB (publ)'s Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Enzymatica AB (publ)'s P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Enzymatica AB (publ)'s stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Enzymatica AB (publ)’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Enzymatica AB (publ) stock

What is the price-to-earnings ratio of Enzymatica AB (publ)?

The price-earnings ratio of Enzymatica AB (publ) is currently 8.85.

How has the price-earnings ratio of Enzymatica AB (publ) changed compared to last year?

The price-to-earnings ratio of Enzymatica AB (publ) has increased by 1.37% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Enzymatica AB (publ) high compared to other companies?

Yes, the price-to-earnings ratio of Enzymatica AB (publ) is high compared to other companies.

How does an increase in the price-earnings ratio of Enzymatica AB (publ) affect the company?

An increase in the price-earnings ratio of Enzymatica AB (publ) would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Enzymatica AB (publ) affect the company?

A decrease in the price-earnings ratio of Enzymatica AB (publ) would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Enzymatica AB (publ)?

Some factors that influence the price-earnings ratio of Enzymatica AB (publ) are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Enzymatica AB (publ) pay?

Over the past 12 months, Enzymatica AB (publ) paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Enzymatica AB (publ) is expected to pay a dividend of 0 SEK.

What is the dividend yield of Enzymatica AB (publ)?

The current dividend yield of Enzymatica AB (publ) is .

When does Enzymatica AB (publ) pay dividends?

Enzymatica AB (publ) pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Enzymatica AB (publ)?

Enzymatica AB (publ) paid dividends every year for the past 0 years.

What is the dividend of Enzymatica AB (publ)?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Enzymatica AB (publ) located?

Enzymatica AB (publ) is assigned to the 'Health' sector.

Wann musste ich die Aktien von Enzymatica AB (publ) kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Enzymatica AB (publ) from 8/18/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 8/18/2024.

When did Enzymatica AB (publ) pay the last dividend?

The last dividend was paid out on 8/18/2024.

What was the dividend of Enzymatica AB (publ) in the year 2023?

In the year 2023, Enzymatica AB (publ) distributed 0 SEK as dividends.

In which currency does Enzymatica AB (publ) pay out the dividend?

The dividends of Enzymatica AB (publ) are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Enzymatica AB (publ)

Our stock analysis for Enzymatica AB (publ) Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Enzymatica AB (publ) Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.